Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Delon La Puma

Delon La Puma

Institutions of which they are part

Research technician
Clinical Neuroimmunology
Vall Hebron Institut de Recerca
Delon La Puma

Delon La Puma

Delon La Puma

Institutions of which they are part

Research technician
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Related news

Dr Mar Tintoré and Dr Álvaro Cobo Calvo

Ovarian reserve does not predict the course of multiple sclerosis

Anti-Müllerian hormone had been proposed as a potential biomarker for predicting disease prognosis in women, but this study shows that the observed association is explained by patients’ chronological age.

Els Drs. Montalban, Tintoré i Tur

Vall d’Hebron takes a further step towards individualized prediction of multiple sclerosis

The Spider-MS tool estimates the probability that a patient will experience various long-term clinical events and will help personalize the follow-up and treatment of each person living with the disease.

Equip de Vall d'Hebron que ha participat en els estudis

Vall d’Hebron confirms the safety of live attenuated vaccines in multiple sclerosis

The results show that live attenuated vaccines against measles, rubella, mumps and varicella do not increase the risk of relapses in people with multiple sclerosis.

See more

Related professionals

Ángeles Mesas Idáñez

Ángeles Mesas Idáñez

Clinical Pharmacology
Read more
Nerea Rayo Garcia

Nerea Rayo Garcia

Research assistant
Reconstructive Surgery of the Locomotor System
Read more
Irene Perona Gómez

Irene Perona Gómez

Research technician
Epidemiology and Public Health
Read more
David Téllez Velasco

David Téllez Velasco

Research technician
Multidisciplinary Nursing Research Group
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.